We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




AI Identifies Non-Smokers at High Risk for Lung Cancer from Single Chest X-Ray

By HospiMedica International staff writers
Posted on 08 Dec 2023

Lung cancer is currently the leading cause of cancer mortality. More...

Notably, 10-20% of lung cancer cases are diagnosed in individuals classified as "never-smokers" – those who have either never smoked or have smoked fewer than 100 cigarettes in their lifetime. The prevalence of lung cancer in never-smokers is increasing, and these cases are often more advanced at the time of discovery due to the lack of early detection methods typically used for smokers. Now, a new study has found that an artificial intelligence (AI) tool is capable of identifying non-smokers at high risk for lung cancer by analyzing routine chest X-ray images.

Conducted by the Massachusetts General Hospital (MGH, Boston, MA, USA), this study aimed to enhance the prediction of lung cancer risk in never-smokers. The research team employed a deep learning model, a sophisticated form of AI, to analyze chest X-ray images from the electronic medical record, searching for patterns indicative of disease. The deep learning model, named "CXR-Lung-Risk," was trained using 147,497 chest X-rays from 40,643 asymptomatic individuals, both smokers and never-smokers. This model was designed to assess lung-related mortality risk from a single chest X-ray.

The effectiveness of the model was then tested on a separate cohort of never-smokers who underwent routine outpatient chest X-rays between 2013 and 2014. The primary measure was the incidence of lung cancer within six years, identified via International Classification of Disease codes. The model categorized the risk scores into low, moderate, and high-risk groups based on predetermined risk thresholds. In the study group of 17,407 patients, averaging 63 years of age, the model classified 28% as high risk, and within this group, 2.9% later had a diagnosis of lung cancer. The high-risk group surpassed the 1.3% six-year risk threshold where lung cancer screening CT is recommended by the US National Comprehensive Cancer Network guidelines. After taking into account age, sex, race, previous lower respiratory tract infection, and prevalent chronic obstructive pulmonary disease, the high-risk group still had a 2.1 times greater risk of developing lung cancer than the low-risk group.

"This AI tool opens the door for opportunistic screening for never-smokers at high risk of lung cancer, using existing chest X-rays in the electronic medical record," said senior author Michael T. Lu, M.D., M.P.H., director of artificial intelligence and co-director of CIRC at MGH. "Since cigarette smoking rates are declining, approaches to detect lung cancer early in those who do not smoke are going to be increasingly important."

Related Links:
MGH


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Amplatzer Paraclose PVL Occluder is a minimally invasive device for paravalvular leak closure, offering an alternative to repeat open-heart surgery. (Photo courtesy of Abbott)

FDA Approves First Transcatheter Device for Paravalvular Leak Closure

Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences

Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.